PFE · earnings call history
Pfizer Inc. Q2 FY26 — Strong Non-COVID Performance and Raised Revenue Guidance
Read the briefPfizer Q1 FY26 — Strong Start with Pipeline Progress and Post-2028 Growth Clarity
Read the briefPfizer Q4 FY25 — Strong Execution and GLP-1 Progress
Read the briefPfizer Q3 FY25 — Strong Non-COVID Performance and Strategic Pipeline Progress
Read the briefPfizer Q2 FY25 — Strong Operational Performance and Pipeline Progress Amid Policy Headwinds
Read the briefPfizer Q4 FY24 — Strong Execution and Pipeline Progress
Read the briefBrowse all US companies on the earnings-call register.